Back to Search
SHANNON FLYNN, PHARMD
PHARMD
Pharmacist
NPI: 1619563731Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
S024121(AZ)
Research & Publications (20)
Survey design from the ground up: collaboratively creating the Toronto Teen Survey.
PMID 18367639·Health Promot Pract·2010
8-other
Predictors of starting to smoke cigarettes in patients with first episode psychosis.
PMID 19162444·Schizophr Res·2009
8-other
Comparison of single bout effects of bicycle training versus locomotor training on paired reflex depression of the soleus H-reflex after motor incomplete spinal cord injury.
PMID 19577036·Arch Phys Med Rehabil·2009
4-observational
Orbital metastasis of keratinizing squamous cell cervical carcinoma with giant cells. A case report.
PMID 17975710·Int Ophthalmol·2009
5-case
Longitudinal Outcomes of GastroIntestinal symptoms in Canada (LOGIC): key factors for an effective patient retention in observational studies.
PMID 19182307·Can J Clin Pharmacol·2009
4-observational
An economic justification for open access to essential medicine patents in developing countries.
PMID 19493066·J Law Med Ethics·2009
8-other
Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models.
PMID 19332332·Neurotherapeutics·2009
7-preclinical
Studies on a series of potent, orally bioavailable, 5-HT(1) receptor ligands--part II.
PMID 19071020·Bioorg Med Chem Lett·2009
7-preclinical
Genetic variation at the TNF-alpha promoter and malaria susceptibility in rhesus (Macaca mulatta) and long-tailed (Macaca fascicularis) macaques.
PMID 19570728·Infect Genet Evol·2009
7-preclinical
Adaptation of postural responses during different standing perturbation conditions in individuals with incomplete spinal cord injury.
PMID 18774296·Gait Posture·2009
8-other
Gender differences in delayed-type hypersensitivity response: effects of stress and coping in first-year law students.
PMID 19162169·Brain Behav Immun·2009
4-observational
Identification of small molecule inhibitors of proline-rich tyrosine kinase 2 (Pyk2) with osteogenic activity in osteoblast cells.
PMID 19648005·Bioorg Med Chem Lett·2009
7-preclinical
New quinoline NK3 receptor antagonists with CNS activity.
PMID 19117759·Bioorg Med Chem Lett·2009
7-preclinical
Discovery of a potent and selective c-Kit inhibitor for the treatment of inflammatory diseases.
PMID 18554909·Bioorg Med Chem Lett·2008
7-preclinical
Characterization of endogenous plasmids from Lactobacillus salivarius UCC118.
PMID 18390685·Appl Environ Microbiol·2008
8-other
Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis.
PMID 18311900·J Med Chem·2008
7-preclinical
Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities.
PMID 19053761·J Med Chem·2008
7-preclinical
Discovery of aryl aminoquinazoline pyridones as potent, selective, and orally efficacious inhibitors of receptor tyrosine kinase c-Kit.
PMID 18447379·J Med Chem·2008
7-preclinical
Phoenix rises, with Tucson's help: establishing the first four-year allopathic program in the nation's fifth largest city.
PMID 18046113·Acad Med·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 15310 N ORACLE RD
TUCSON, AZ 85739 - Phone
- (520) 575-7301
Quick Facts
- NPI
- 1619563731
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile